NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DXC Technology Company ("DXC" or "the Company") (NYSE:DXC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for […]

NEW YORK CITY, NY / ACCESSWIRE / September 19, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Five Below, Inc. ("Five Below" or "the Company") (NASDAQ:FIVE) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Arbor Realty Trust ("Arbor Realty" or "the Company") (NYSE:ABR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against CrowdStrike Holdings, Inc. ("CrowdStrike" or "the Company") (NASDAQ:CRWD) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) — Asante Gold Corporation (CSE: ASE | GSE: ASG | FRANKFURT:1A9 | U.S.OTC: ASGOF) (“Asante” or the “Company”) is pleased to announce that it has received approval from the Securities and Exchange Commission

Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for Fill/Finish of Latest Sterile Injectable Pharmaceutical and Biopharmaceutical Products Current Capacity More than Doubles with New Filler CHASKA, Minn., Sept. 19, 2024 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully

LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (Nasdaq: ARQQ) (“Arqit” or the “Company”), a leader in quantum safe encryption, today announces that, following approval by the Company’s shareholders at its annual general meeting held on September 18, 2024, the Company’s Board of Directors has determined to effect a 25:1 reverse share split

TSX Venture Exchange (TSX-V):GRGFrankfurt Stock Exchange (FSE):G6AOTCQB Venture Market (OTCQB):GARWF Golden Arrow Resources Corporation (TSXV:GRG) (FSE: G6A) (OTCQB: GARWF), (“Golden Arrow”or the”Company”)is pleased to announce that it has engaged the services of a Chilean environmental consultancy firm for the preparation and submission of an Environmental Impact Statement (“Declaración de Impacto Ambiental” or “DIA”) for the

The leading publication in graduate business education compiles the most well-funded MBA startups in it’s annual feature Poets&Quants presents an annual comprehensive list of the 100 highest-funded MBA startups of 2024. Done each year since 2014, MBA-founded startups were solicited from the world’s best MBA programs to compile a list based on a single metric:

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provided an update on its tradipitant development program. https://mma.prnewswire.com/media/2090054/VandaLogo_Logo.jpg On September 18, 2024, the U.S. Food and Drug Administration (FDA) declined to approve Vanda’s New Drug Application (NDA) of tradipitant for the treatment of symptoms in gastroparesis, providing Vanda with a Complete Response Letter (CRL). Gastroparesis is a